Clinical trial
Vanderbilt University Spasticity Management Program Evaluation Plan
NCT00179114 · Vanderbilt University, Other · Completed
Key facts
| NCT number | NCT00179114 |
|---|---|
| Title | Vanderbilt University Spasticity Management Program Evaluation Plan |
| Official title | Vanderbilt University Spasticity Management Program Evaluation Plan |
| Lead sponsor | Vanderbilt University, Other |
| Collaborators | Allergan Industry Medtronic |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Spasticity |
| Intervention type | Drug |
| Interventions | Botulinum Toxin Type A, Intrathecal baclofen administered by the Medtronic SyncroMed(TM) pump (ITB) |
| Enrollment | 20 |
| Start date | Aug 1, 2002 |
| Completion | Feb 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Aug 20, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: